ArticleBiomedicines2025

Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling.

Ting Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.